CAJ — Capitol Health Income Statement
0.000.00%
Last trade - 00:00
- AU$255.65m
- AU$381.01m
- AU$209.59m
- 85
- 65
- 96
- 94
R2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 149 | 154 | 178 | 184 | 210 |
Cost of Revenue | |||||
Gross Profit | 137 | 141 | 165 | 171 | 194 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 119 | 148 | 153 | 167 | 215 |
Operating Profit | 29.8 | 5.66 | 24.7 | 17.1 | -5.55 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 28.2 | 2.16 | 19.4 | 15.9 | -10.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 24.3 | 1.09 | 12 | 11 | -11.3 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 24.3 | 0.865 | 11.9 | 11 | -11.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 24.3 | 0.865 | 11.9 | 11 | -11.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.013 | 0.004 | 0.013 | 0.012 | 0.002 |
Dividends per Share |